NP / PA
Benhoff, Julie
Benhoff, Julie was paid $225K by Medicaid between Mar 2018 and Aug 2024, across 20 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoBENHOFF, JULIE
ALTON, IL 62002
ALTON, IL 62002
33aNPI1902130941assigned 09/23/2009
33bProvider typeNurse Practitioner
28Total paid$225K
24GClaims5,121
24DCodes billed20
24AFirst – last monthMar 2018 – Aug 2024
Compared with peers
Next to other Nurse Practitioner providers in Illinois
Rank by total paid#132 of 1,687
Median peer was paid$22K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43 | $2K | |
| 2019 | 137 | $6K | |
| 2020 | 153 | $8K | |
| 2021 | 105 | $8K | |
| 2022 | 54 | $5K | |
| 2023 | 2,269 | $87K | |
| 2024incomplete | 2,360 | $109K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 848 | 756 | $65K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 649 | 566 | $33K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14% | 376 | 337 | $31K |
| 99220 | 11% | 396 | 369 | $25K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.9% | 303 | 277 | $15K |
| 99000 | 6.3% | 618 | 559 | $14K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.0% | 194 | 175 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.8% | 265 | 192 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.6% | 115 | 88 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 293 | 243 | $5K |
| 99223 | Prolong inpt eval add15 m | 1.8% | 124 | 121 | $4K |
| 87428 | 1.3% | 46 | 42 | $3K |
8 more codes
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.2% | 65 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 243 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 69 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 23 | $2K |
| 81002 | <1% | 294 | $759.31 | |
| 87210 | <1% | 122 | $573.40 | |
| 81025 | <1% | 30 | $168.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 48 | $109.24 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.